| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |